The Myasthenia Gravis Foundation of America (MGFA) is dedicated to improving the lives of individuals affected by myasthenia gravis, a chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness. Founded in 1952, the MGFA aims for a world without MG by advocating for patient support, funding research for better treatments, and providing education and resources for patients, caregivers, and healthcare professionals.
1952
13-5672224
$11.36 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
An app designed to help patients manage their myasthenia gravis.
A support line available to assist individuals affected by MG.
Annual fundraising events that unite the community to raise awareness and support for MG.
MGFA Global MG Patient Registry
Started a comprehensive registry to collect and analyze data on patients with myasthenia gravis.
Increased Awareness
Significantly raised awareness about myasthenia gravis through various campaigns.
Funded Research Grants
Provided funding for groundbreaking research aimed at understanding and treating myasthenia gravis.
2023-06-12
Annual MGAA Conference bringing together patients, families, and medical professionals.
2023-08-15
Community health fair providing resources and information about myasthenia gravis.
2024-11-02
A community health fair connecting patients with resources and support.
Learn More2025-03-23
An annual gathering for patients and their families to learn and share experiences.
Learn MoreA peer support program connecting individuals with similar experiences.
Learn MoreOverall Score
75
84
/100
Program Expense Ratio
74.63%
10
/20
Program Revenue Growth
138.59%
20
/20
Leverage Ratio
0.1171
18
/20
Working Capital Ratio
2.647
16
/20
Fundraising Efficiency
0.1218
20
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 3.609M | 82.23% |
Program Services | 452.1K | 10.30% |
Investment Income | 252.4K | 5.75% |
Sales of Non-Inventory Assets | 22.84K | 0.52% |
Other Notable Sources | 3.946K | 0.09% |
Total Revenue | 4.389M | 100.00% |